CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glaise, D.
Right arrow Articles by Guguen-Guillouzo, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glaise, D.
Right arrow Articles by Guguen-Guillouzo, C.

Cell Growth & Differentiation, Vol 9, Issue 2 165-176, Copyright © 1998 by American Association of Cancer Research


ARTICLES

Cell cycle gene regulation in reversibly differentiated new human hepatoma cell lines

D Glaise, GP Ilyin, P Loyer, S Cariou, M Bilodeau, J Lucas, A Puisieux, M Ozturk and C Guguen-Guillouzo
INSERM U49, Hopital Pontchaillou, Rennes, France.

Several novel differentiated cell lines have been derived from a human hepatocarcinoma named HBG. Analysis of their functional properties evidenced a gradual differentiation process as they became confluent and a remarkable stability of the whole quiescent population for at least 6 weeks. However, when replated at low density after several weeks of quiescence, the differentiated cells were able to rapidly reverse to active proliferation, accompanied by transient dedifferentiation. Demonstration that the differentiated hepatic cells were growth-arrested in G1 phase was provided by the increased number of cells with 2C DNA content and decreased expression of S-phase markers. Characteristic features of oncogenes and cell cycle genes were defined during the differentiation process: (a) a biphasic expression of c-myc, with the latter wave covering the quiescence period; (b) opposite kinetics of c-Ki-ras and of N-ras expression with a pattern of changes paralleling that of c-myc; and (c) a decrease of cyclin D1 protein expression and of the cyclin D1-associated kinase activity. The mechanisms by which quiescent differentiated cells might reinitiate active proliferation were analyzed by studying several genes involved in cell growth and death regulation. We found: (a) a point mutation and loss of the specific activity of the tumor suppressor gene p53 without alteration of the apoptotic response to transforming growth factor beta1; (b) a gradual decrease of retinoblastoma protein, which was constantly present, mainly in a hyperphosphorylated form; and (c) an increase of cyclin-dependent kinase inhibitor p27 expression in confluent differentiating cells, as expected, whereas, surprisingly, a disappearance of the p21 protein was observed in parallel. These data may reflect specific mechanisms of cell cycle regulation in liver parenchymal cells through which these cells can proceed to control their reversible differentiation program.


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
L. Andrieux, S. Langouet, A. Fautrel, F. Ezan, J. A. Krauser, J. F. Savouret, F. P. Guengerich, G. Baffet, and A. Guillouzo
Aryl Hydrocarbon Receptor Activation and Cytochrome P450 1A Induction by the Mitogen-Activated Protein Kinase Inhibitor U0126 in Hepatocytes
Mol. Pharmacol., April 1, 2004; 65(4): 934 - 943.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
C. Armengol, G. Tarafa, L. Boix, M. Sole, R. Queralt, D. Costa, O. Bachs, J. Bruix, and G. Capella
Orthotopic Implantation of Human Hepatocellular Carcinoma in Mice: Analysis of Tumor Progression and Establishment of the BCLC-9 Cell Line
Clin. Cancer Res., March 15, 2004; 10(6): 2150 - 2157.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. P. Ilyin, D. Glaise, D. Gilot, G. Baffet, and C. Guguen-Guillouzo
Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth
Am J Physiol Gastrointest Liver Physiol, July 1, 2003; 285(1): G115 - G127.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Carnesecchi, K. Langley, F. Exinger, F. Gosse, and F. Raul
Geraniol, a Component of Plant Essential Oils, Sensitizes Human Colonic Cancer Cells to 5-Fluorouracil Treatment
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 625 - 630.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Fiorentino, A. Altimari, A. D'Errico, B. Cukor, C. Barozzi, M. Loda, and W. F. Grigioni
Acquired Expression of p27 Is a Favorable Prognostic Indicator in Patients with Hepatocellular Carcinoma
Clin. Cancer Res., October 1, 2000; 6(10): 3966 - 3972.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1998 by the American Association of Cancer Research.